DNA from frozen tissues was extracted using the
QIAamp DNA Mini Kit (Qiagen, Germantown, MD, USA). FFPE tissue DNA was extracted using
GeneJet FFPE DNA Purification Kit and
RecoverAll™ Total Nucleic Acid Isolation (Invitrogen, Thermo Fisher Scientific, Carslbad, CA, USA), following the manufacturer’s instructions, with overnight lysis instead of the suggested 1–2 h for FFPE tissue. Germline DNA was purified from whole blood samples or buffy coat using the Wizard
® Genomic DNA Purification Kit (Promega, Madison, WI, USA), according to manufacturer’s protocol.
Purified DNA was quantified using the
Qubit(™) dsDNA HS Assay and Quant-IT(™) Picogreen
® dsDNA Reagent Kit (Invitrogen, Thermo Fisher Scientific, Carslbad, CA, USA). The purity of DNA was assessed by measuring the 260/280 nm absorbance ratio. For FFPE samples, fragment length and degradation were assessed using the
HS Genomic DNA Analysis Kit (DNF-488) in a
Fragment Analyzer (Agilent, formerly Advanced Analytical). DNA ranged from >1000 bp to 200 bp. Samples with <200 bp are not recommended for processing with the TumorSec workflow.
Salvo M., González-Feliú E., Toro J., Gallegos I., Maureira I., Miranda-González N., Barajas O., Bustamante E., Ahumada M., Colombo A., Armisén R., Villamán C., Ibañez C., Bravo M.L., Sanhueza V., Spencer M.L., de Toro G., Morales E., Bizama C., García P., Carrasco A.M., Gutiérrez L., Bermejo J.L., Verdugo R.A, & Marcelain K. (2021). Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America. Journal of Personalized Medicine, 11(9), 899.